TY - JOUR
T1 - Enhancement of Solubility and Dissolution Rate Using Tailored Rapidly Dissolving Oral Films Containing Felodipine Solid Dispersion
T2 - In Vitro Characterization and Ex Vivo Studies
AU - Sana,
AU - Salwa,
AU - Shirodkar, Rupesh Kalidas
AU - Kumar, Lalit
AU - Verma, Ruchi
N1 - Funding Information:
The authors would like to sincerely thank the All India Council for Technical Education (AICTE), New Delhi (India), for providing National Doctoral Fellowship to Salwa. We also extend our gratitude to the Manipal College of Pharmaceutical Sciences, Manipal (India), for their constant support round the clock.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - Purpose: The goal of the present investigation was to establish felodipine (FDP) solid dispersion-loaded transmucosal buccal films which may help to increase its solubility and avoid hepatic first-pass metabolism to boost its oral bioavailability leading to better treatment of hypertension. Methods: The solid dispersion was prepared using fusion method. The effect of varying ratios of poloxamer 407 on dissolution of FDP was studied. Prepared FDP solid dispersions were characterized concerning FTIR, DSC, PXRD, and SEM. Further, the standardized FDP solid dispersion was incorporated into RDOFs that were fabricated by mold casting technique. Results: SEM micrographs of RDOFs revealed the presence of FDP solid dispersion in the matrix of the polymer. Ex vivo permeation of the drug from FDP-loaded RDOF and FDP solid dispersion-loaded RDOF across porcine buccal mucosa was found to be 17.3 ± 0.11% and 84.81 ± 7.19%, respectively in 90 min. Conclusion: Obtained results conclude that the prepared FDP solid dispersion-loaded RDOFs may be a useful approach to augment the oral bioavailability of FDP by ameliorating its solubility and the rate of dissolution, and it can also reduce hepatic first-pass metabolism. Graphical Abstract: [Figure not available: see fulltext.].
AB - Purpose: The goal of the present investigation was to establish felodipine (FDP) solid dispersion-loaded transmucosal buccal films which may help to increase its solubility and avoid hepatic first-pass metabolism to boost its oral bioavailability leading to better treatment of hypertension. Methods: The solid dispersion was prepared using fusion method. The effect of varying ratios of poloxamer 407 on dissolution of FDP was studied. Prepared FDP solid dispersions were characterized concerning FTIR, DSC, PXRD, and SEM. Further, the standardized FDP solid dispersion was incorporated into RDOFs that were fabricated by mold casting technique. Results: SEM micrographs of RDOFs revealed the presence of FDP solid dispersion in the matrix of the polymer. Ex vivo permeation of the drug from FDP-loaded RDOF and FDP solid dispersion-loaded RDOF across porcine buccal mucosa was found to be 17.3 ± 0.11% and 84.81 ± 7.19%, respectively in 90 min. Conclusion: Obtained results conclude that the prepared FDP solid dispersion-loaded RDOFs may be a useful approach to augment the oral bioavailability of FDP by ameliorating its solubility and the rate of dissolution, and it can also reduce hepatic first-pass metabolism. Graphical Abstract: [Figure not available: see fulltext.].
UR - http://www.scopus.com/inward/record.url?scp=85148608030&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148608030&partnerID=8YFLogxK
U2 - 10.1007/s12247-023-09716-7
DO - 10.1007/s12247-023-09716-7
M3 - Article
AN - SCOPUS:85148608030
SN - 1872-5120
JO - Journal of Pharmaceutical Innovation
JF - Journal of Pharmaceutical Innovation
ER -